Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEVG.L Share News (EVG)

  • There is currently no data for EVG

Record breaking year at Evolution

Thu, 25th Mar 2010 08:25
2009 was a record breaking year on many fronts for investment management firm Evolution Group.Group income, private client income, investment banking income and assets under management all hit new highs.Total income more than doubled to £129.4m in 2009 from £63.9m, with investment banking income soaring 183% to £87m while private client income rose 23% to £42.4m.Assets under management jumped 37% to a record level of £5.2bn from £3.8bn the year before. Fund inflows at £322m were down from £550m the year before, but the number of private client accounts grew from 11,803 to 14,343. Statutory profit before tax was £11.1m, compared to a loss of £12.7m the year before. The company’s own adjusted profit before tax measurement showed profitability improving to £18,4m from £2.9m in 2008. ‘While activity levels last year remained depressed and investor sentiment proved highly sensitive to risk and volatility, the group nevertheless delivered an extremely impressive financial performance, with significant growth in both income and profit,’ said Martin Gray, chairman of Evolution.The final dividend has been increased by 34% to 1.70p, making the full year dividend 2.50p, up 24% on 2008’s level.

Related News

TRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading well
25 Apr 2024

TRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

TRADING UPDATES: Northcoders launches bootcamp; Schroder invests
4 Apr 2024

TRADING UPDATES: Northcoders launches bootcamp; Schroder invests

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat
19 Mar 2024

EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reporte...

EVG.L News

Evgen agrees fresh licensing deal with Spanish institutions
18 Jan 2022

Evgen agrees fresh licensing deal with Spanish institutions

(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced a memorandum of understanding with the University of Seville, Consej...

Evgen signs agreement for Spanish institutions' sulfoaphane analogues
18 Jan 2022

Evgen signs agreement for Spanish institutions' sulfoaphane analogues

Evgen signs agreement for Spanish institutions' sulfoaphane analogues

EARNINGS UPDATES: Carr's beats expectations; Premier assets hit record
7 Dec 2021

EARNINGS UPDATES: Carr's beats expectations; Premier assets hit record

EARNINGS UPDATES: Carr's beats expectations; Premier assets hit record

UK earnings, trading statements calendar - next 7 days
30 Nov 2021

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

TRADING UPDATES: Permanent TSB sells loan portfolio; Dekel output up
10 Nov 2021

TRADING UPDATES: Permanent TSB sells loan portfolio; Dekel output up

TRADING UPDATES: Permanent TSB sells loan portfolio; Dekel output up

IN BRIEF: Evgen Pharma's SFX-01 effective on tumour cells
20 Sep 2021

IN BRIEF: Evgen Pharma's SFX-01 effective on tumour cells

IN BRIEF: Evgen Pharma's SFX-01 effective on tumour cells

IN BRIEF: Evgen SFX-01 granted orphan drug designation by US FDA
2 Sep 2021

IN BRIEF: Evgen SFX-01 granted orphan drug designation by US FDA

IN BRIEF: Evgen SFX-01 granted orphan drug designation by US FDA

Evgen pleased with preclinical data on SFX-01
13 Jul 2021

Evgen pleased with preclinical data on SFX-01

(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced preclinical data demonstrating that 'SFX-01' was effective in in-vit...